Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Booster Vaccination Study to Assess Immunogenicity & Safety of a Dose of GSK Biologicals' Mencevax™ ACWY & 1/5th of a Dose of Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00291343
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:54.767266+00:00
Published At
2017-08-03T00:00:00+00:00
Record Updated At
2018-06-06
Results Posted At
2017-08-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-06"
protocolSection.identificationModule.nctId
"NCT00291343"
protocolSection.identificationModule.officialTitle
"Booster Vaccination Study to Assess Immunogenicity \u0026 Safety of a Dose of GSK Biologicals\u0027 Mencevax\u2122 ACWY \u0026 1/5th of a Dose of Mencevax\u2122 ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-08-03"

Study condition terms

  • Infections, Meningococcal (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.